-
2
-
-
0142091400
-
Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor
-
DOI 10.1073/pnas.2034936100
-
Gherardi E, Youles ME, Miguel RN, Blundell TL, Iamele L, Gough J, et al. Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 2003; 100: 12039-44. (Pubitemid 37271511)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.21
, pp. 12039-12044
-
-
Gherardi, E.1
Youles, M.E.2
Miguel, R.N.3
Blundell, T.L.4
Iamele, L.5
Gough, J.6
Bandyopadhyay, A.7
Hartmann, G.8
Butler, P.J.G.9
-
3
-
-
0034526510
-
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
-
Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 2000; 106: 1511-9. (Pubitemid 32038589)
-
(2000)
Journal of Clinical Investigation
, vol.106
, Issue.12
, pp. 1511-1519
-
-
Nakamura, T.1
Mizuno, S.2
Matsumoto, K.3
Sawa, Y.4
Matsuda, H.5
Nakamura, T.6
-
4
-
-
19544389146
-
C-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention
-
DOI 10.1016/j.canlet.2004.09.044, PII S0304383504007657
-
Christensen JG, Burrows J, Salgia R. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett 2005; 225: 1-26. (Pubitemid 40732764)
-
(2005)
Cancer Letters
, vol.225
, Issue.1
, pp. 1-26
-
-
Christensen, J.G.1
Burrows, J.2
Salgia, R.3
-
5
-
-
66149135285
-
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma
-
Seiwert TY, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, El Dinali M, et al. The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res 2009; 69: 3021-31.
-
(2009)
Cancer Res
, vol.69
, pp. 3021-3031
-
-
Seiwert, T.Y.1
Jagadeeswaran, R.2
Faoro, L.3
Janamanchi, V.4
Nallasura, V.5
El Dinali, M.6
-
6
-
-
66649131963
-
HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer
-
Knowles LM, Stabile LP, Egloff AM, Rothstein ME, Thomas SM, Gubish CT, et al. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer. Clin Cancer Res 2009; 15: 3740-50.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3740-3750
-
-
Knowles, L.M.1
Stabile, L.P.2
Egloff, A.M.3
Rothstein, M.E.4
Thomas, S.M.5
Gubish, C.T.6
-
7
-
-
55449116539
-
Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer
-
Okuda K, Sasaki H, Yukiue H, Yano M, Fujii Y. Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer. Cancer Sci 2008; 99: 2280-5.
-
(2008)
Cancer Sci
, vol.99
, pp. 2280-2285
-
-
Okuda, K.1
Sasaki, H.2
Yukiue, H.3
Yano, M.4
Fujii, Y.5
-
8
-
-
81255138189
-
A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3
-
Liu X, Wang Q, Yang G, Marando C, Koblish HK, Hall LM, et al. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3. Clin Cancer Res 2011; 17: 7127-38.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 7127-7138
-
-
Liu, X.1
Wang, Q.2
Yang, G.3
Marando, C.4
Koblish, H.K.5
Hall, L.M.6
-
9
-
-
33748981862
-
The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia
-
DOI 10.1016/j.jpedsurg.2006.05.058, PII S0022346806003964
-
Toiyama Y, Miki C, Inoue Y, Okugawa Y, Tanaka K, Kusunoki M. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. Int J Cancer 2009; 125: 1657-62. (Pubitemid 44441370)
-
(2006)
Journal of Pediatric Surgery
, vol.41
, Issue.10
, pp. 1657-1662
-
-
Uchida, K.1
Inoue, M.2
Otake, K.3
Yoshiyama, S.4
Toiyama, Y.5
Hiro, J.6
Araki, T.7
Miki, C.8
Kusunoki, M.9
-
10
-
-
58149347700
-
Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer
-
Gupta A, Karakiewicz PI, Roehrborn CG, Lotan Y, Zlotta AR, Shariat SF. Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer. Clin Cancer Res 2008; 14: 7385-90.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 7385-7390
-
-
Gupta, A.1
Karakiewicz, P.I.2
Roehrborn, C.G.3
Lotan, Y.4
Zlotta, A.R.5
Shariat, S.F.6
-
11
-
-
63849163410
-
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients
-
Cappuzzo F, Marchetti A, Skokan M, Rossi E, Gajapathy S, Felicioni L, et al. Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. J Clin Oncol 2009; 27: 1667-74.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1667-1674
-
-
Cappuzzo, F.1
Marchetti, A.2
Skokan, M.3
Rossi, E.4
Gajapathy, S.5
Felicioni, L.6
-
12
-
-
33847326735
-
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome
-
DOI 10.1016/j.canlet.2006.07.007, PII S0304383506004800
-
Kammula US, Kuntz EJ, Francone TD, Zeng Z, Shia J, Landmann RG, et al. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Lett 2007; 248: 219-28. (Pubitemid 46330555)
-
(2007)
Cancer Letters
, vol.248
, Issue.2
, pp. 219-228
-
-
Kammula, U.S.1
Kuntz, E.J.2
Francone, T.D.3
Zeng, Z.4
Shia, J.5
Landmann, R.G.6
Paty, P.B.7
Weiser, M.R.8
-
13
-
-
0036217866
-
Invasive growth: From development to metastasis
-
DOI 10.1172/JCI200215392
-
Comoglio PM, Trusolino L. Invasive growth: from development to metastasis. J Clin Invest 2002; 109: 857-62. (Pubitemid 34275105)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.7
, pp. 857-862
-
-
Comoglio, P.M.1
Trusolino, L.2
-
14
-
-
0036221263
-
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
-
DOI 10.1172/JCI200215418
-
Danilkovitch-Miagkova A,Zbar B. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 2002; 109: 863-7. (Pubitemid 34275106)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.7
, pp. 863-867
-
-
Danilkovitch-Miagkova, A.1
Zbar, B.2
-
15
-
-
78649420006
-
MET signalling: Principles and functions in development, organ regeneration and cancer
-
Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. N at R ev Mol Cell Biol 2010; 11: 834-48.
-
(2010)
N at R Ev Mol Cell Biol
, vol.11
, pp. 834-848
-
-
Trusolino, L.1
Bertotti, A.2
Comoglio, P.M.3
-
16
-
-
0242331653
-
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation
-
DOI 10.1073/pnas.2135113100
-
Zhang YW, Su Y, Volpert OV, Woude GFV. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 2003; 100: 12718-23. (Pubitemid 37339965)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.22
, pp. 12718-12723
-
-
Zhang, Y.-W.1
Su, Y.2
Volpert, O.V.3
Vande Woude, G.F.4
-
17
-
-
0021285134
-
Partial formation and characterization of hepatocyte growth factor from serum of hepatectomized rats
-
Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-9. (Pubitemid 14073577)
-
(1984)
Biochemical and Biophysical Research Communications
, vol.122
, Issue.3
, pp. 1450-1459
-
-
Nakamura, T.1
Nawa, K.2
Ichihara, A.3
-
18
-
-
0025734655
-
Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET
-
Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 1991; 6: 501-4. (Pubitemid 21924112)
-
(1991)
Oncogene
, vol.6
, Issue.4
, pp. 501-504
-
-
Naldini, L.1
Vigna, E.2
Narsimhan, R.P.3
Gaudino, G.4
Zarnegar, R.5
Michalopoulos, G.K.6
Comoglio, P.M.7
-
19
-
-
0023661693
-
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
-
Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987; 327: 239-42. (Pubitemid 17071053)
-
(1987)
Nature
, vol.326
, Issue.6119
, pp. 239-242
-
-
Stoker, M.1
Gherardi, E.2
Perryman, M.3
Gray, J.4
-
20
-
-
15844411673
-
Motogenic and morphogenic activity of epithelial receptor tyrosine kinases
-
DOI 10.1083/jcb.133.5.1095
-
Sachs M, Weidner KM, Brinkmann V, Walther I, Obermeier A, Ullrich A, et al. Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J Cell Biol 1996; 133: 1095-107. (Pubitemid 26172514)
-
(1996)
Journal of Cell Biology
, vol.133
, Issue.5
, pp. 1095-1107
-
-
Sachs, M.1
Michael Weidner, K.2
Brinkmann, V.3
Walther, I.4
Obermeier, A.5
Ullrich, A.6
Birchmeier, W.7
-
21
-
-
33746504571
-
Invasive growth: A MET-driven genetic programme for cancer and stem cells
-
DOI 10.1038/nrc1912, PII NRC1912
-
Boccaccio C, Comoglio PM. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006; 6: 637-45. (Pubitemid 44140861)
-
(2006)
Nature Reviews Cancer
, vol.6
, Issue.8
, pp. 637-645
-
-
Boccaccio, C.1
Comoglio, P.M.2
-
23
-
-
0036595629
-
Epithelial-mesenchymal transitions in tumour progression
-
Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-54.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 442-454
-
-
Thiery, J.P.1
-
24
-
-
24644480749
-
Molecular requirements for epithelial-mesenchymal transition during tumor progression
-
DOI 10.1016/j.ceb.2005.08.001, PII S0955067405001043
-
Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-58. (Pubitemid 41267170)
-
(2005)
Current Opinion in Cell Biology
, vol.17
, Issue.5 SPEC. ISSUE.
, pp. 548-558
-
-
Huber, M.A.1
Kraut, N.2
Beug, H.3
-
26
-
-
84880923318
-
A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors
-
Feldman DR, Einhorn LH, Quinn DI, Loriot Y, Joffe JK, Vaughn DJ, et al. A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors. Invest New Drugs 2013; 31:1016-22.
-
(2013)
Invest New Drugs
, vol.31
, pp. 1016-1022
-
-
Feldman, D.R.1
Einhorn, L.H.2
Quinn, D.I.3
Loriot, Y.4
Joffe, J.K.5
Vaughn, D.J.6
-
27
-
-
84874787799
-
Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial
-
Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, et al. Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial. J Clin Oncol 2013; 31: 412-9.
-
(2013)
J Clin Oncol
, vol.31
, pp. 412-419
-
-
Smith, D.C.1
Smith, M.R.2
Sweeney, C.3
Elfiky, A.A.4
Logothetis, C.5
Corn, P.G.6
-
28
-
-
77956379695
-
Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy
-
Wang MH, Padhye SS, Guin S, Ma Q, Zhou YQ. Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy. Acta Pharmacol Sin 2010; 31: 1181-8.
-
(2010)
Acta Pharmacol Sin
, vol.31
, pp. 1181-1188
-
-
Wang, M.H.1
Padhye, S.S.2
Guin, S.3
Ma, Q.4
Zhou, Y.Q.5
|